Cytokines act on target cells by binding to specific membrane receptors, such as type I/II cytokine receptors, chemokine receptors, and the tumor necrosis factor (TNF) and transforming growth factor (TGF) families. The JAK-STAT signaling pathway is considered a central communication hub for the immune system. In this pathway, activated Janus kinases (JAKs) phosphorylate the receptor to recruit STAT molecules, which dimerize and translocate into the nucleus to modulate the transcription of target genes.

To regulate this system, Suppressor of cytokine signaling (SOCS) molecules function as a negative feedback loop by terminating JAK/STAT signaling. Another critical family is the G-protein-coupled receptors (GPCRs), which detect a wide spectrum of signals to activate second messengers like cAMP and calcium. Furthermore, the TNF superfamily can induce apoptosis through caspases or initiate NF-κB activation to favor cell survival. TGF-β is essential for T cell homeostasis and can induce "alternative activation" M2 macrophages.

Following severe blunt trauma, there is a massive shift in the leukocyte transcriptome, with more than 80% of cellular functions demonstrating altered gene expression within 4 to 12 hours. This coordinated response involves NF-κB, a central transcription factor that regulates gene products expressed after inflammatory stimuli. Activation of NF-κB requires the degradation of the inhibitory protein I-κB, allowing NF-κB to move into the nucleus.

Gene expression is also governed by epigenetic regulation, where modifications like histone acetylation alter DNA accessibility for transcription. At the translational level, microRNAs (miRNAs) serve as important regulators; they typically result in gene silencing by binding to target mRNA transcripts to inhibit protein synthesis or promote degradation.

Neutrophils (PMNs) are the first responders to sites of injury. Once activated, they release toxic effectors and can extrude neutrophil extracellular traps (NETs)—meshworks of chromatin and DNA that immobilize bacteria but can also contribute to further tissue injury. Monocytes and macrophages sense "danger signals" and can adopt different phenotypes: the M1 phenotype is pro-inflammatory, while the M2 phenotype is involved in wound repair and restoring immune homeostasis.

The adaptive immune response is also reshaped. Significant injury triggers a shift from Th1 (cell-mediated) to Th2 (antibody-mediated) immunity. This imbalance, often favoring Th2 lymphocytes, is associated with an increased risk of infectious complications. Additionally, a robust Th17 immune response is often observed early in nonsurvivors. Supporting these processes are dendritic cells, the "professional antigen-presenting cells", and platelets, which release mediators like HMGB1 and TGF-β to facilitate cellular activation. Mast cells also contribute by releasing histamine and cytokines that lead to capillary leakage and immunocyte recruitment.

The vascular endothelium forms a critical barrier but undergoes a procoagulant shift after injury, characterized by the disruption of the glycocalyx. Neutrophil migration across the endothelium follows a regulated sequence: capture (L-selectin), fast rolling, slow rolling (P-selectin), and very slow rolling (E-selectin) before firm adhesion and transmigration. Chemokines enhance this process by creating fixed chemical gradients on cell surfaces.

Several small molecules regulate vascular tone and inflammation:

• Nitric oxide (NO), derived from L-arginine, maintains smooth muscle relaxation and reduces platelet adhesion. During trauma, iNOS is upregulated to modulate cytokine production.

• Prostacyclin (PGI2) is a potent vasodilator and inhibitor of platelet aggregation.

• Endothelins (ETs), particularly ET-1, are powerful vasoconstrictors, ten times more potent than angiotensin II.

• Platelet Activating Factor (PAF) promotes leukocyte adherence, chemotaxis, and the extrusion of NETs.

• Natriuretic peptides (ANP and BNP) are released by the heart; persistently high levels of NT-proBNP in trauma patients are indicative of poor outcomes.

In the hours following injury, the body undergoes a reprioritization of substrate use to preserve vital organ function and support tissue repair. This phase is characterized by augmented metabolic rates and a preference for glucose to fuel obligate glycolytic cells such as neurons and leukocytes. While a healthy adult in a fasting state relies on muscle protein and fat stores, the surgical patient requires approximately 180g of glucose per day to support essential metabolic functions.

[Conclusion]

The systemic response to injury is a highly conserved, universal pathway. By understanding these molecular, cellular, and metabolic mechanisms, clinicians can provide better support for the restoration of homeostasis in the injured patient.